TLRY Tilray

Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup

Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup

Tilray Releases New Product Innovations Across Core Recreational Cannabis Categories from Whole Flower, Beverages, Pre-rolls, and Vapes

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company, through its wholly-owned licensed subsidiaries, Aphria Inc., Hexo Operations Inc., and Truss Beverages Company Limited, announces its latest product lineup and 420 celebratory activations across Canada.

Tilray’s cannabis brands including GOOD SUPPLY®, REDECAN®, BROKEN COAST®, SOLEI®, Mollo®, and XMG® will be activating a series of educational 420 budtender events in stores across Canada in partnership with over 1000 Canadian cannabis retailers nationwide. Cannabis enthusiasts and cannabis-curious consumers alike are invited to learn about Tilray Brands’ products at local cannabis retailers.

In celebration of 420 and the ever-changing landscape of cannabis innovation and culture, Tilray Brands invites consumers to explore a new range of diverse cannabis products from its leading brands.

Flower:

  • Space Age Cake: A profoundly potent hybrid offering creamy vanilla, nutty, and ammonia flavours in our signature straight-cut, hemp-wrapped pre-rolls. This Girl Scout Cookies x Snow Lotus cross is everything to love about cookies strains. Now Available in Ontario, Alberta, and British Columbia in 3.5g and 14g.

  • Melon Dream: This sweet sativa-leaning hybrid is a mix of fruit and diesel aromas featuring dominant terpenes of caryophyllene, humulene and limonene, delivering the ultimate mellow vibe. Now available in Ontario and Alberta.

  • EmergenZ and Cherry Cheesecake: Broken Coast presents two exceptional strains for 420 with unique aromas and taste profiles. ‘Cherry Cheesecake,’ delivers a unique trio of cherry, cheese, and sour aromas, and ‘EmergenZ’ energizes the senses, with the zesty flavours of tangerine, citrus, grapefruit, and pine. Now available in Ontario, Alberta, and British Columbia.

Beverages:

  • Non-Carbonated Banana Brain-Freeze and Berry Rocket: ‘Banana Brain-Freeze’ is a symphony of tropical sweetness while Berry Rocket is a flavour fusion of juicy berries. Both feature 10mg of THC and 10mg of CBG along with guarana extract in a 355mL can, now available in Ontario and Alberta with anticipated expansion nationwide.
  • Cold Brews in Peach Cranberry and Wildberry Hibiscus: Both brews are made with refreshing true-to-fruit juice blends and a black tea base. Peach Cranberry is made with 5mg of THC and 10mg of CBG and Wildberry Hibiscus is made with 5mg of THC and 10mg of CBD featuring. Both are available in Ontario, and Peach Cranberry is available in British Columbia, along with further national launches across Canada.
  • Seltzers in Lemon, Mango, and Pineapple: Best sipped slow, each new Mollo Seltzer contains 10mg of high-purity THC formulated with nano-emulsified cannabinoids without any cannabis aftertaste in three fantastic natural flavours, along with its CBG sidekick of 20mg, all in a sleek 355mL can. All flavours are available in Ontario, with Mango and Pineapple available in British Columbia and further national releases coming this summer.

Pre-rolls:

  • ’sCherry on Top’ Blunts: This new two-pack of 1g blunts features fresh flower that delivers a burst of new flavours and aromatic notes of Cosmic Cherry (Sativa), enhanced with zesty lemon sweetness, along with Golden Drizzle (Indica) delivering a delectable blend of sweet and caramelized notes. These perfectly paired blunts come in a slow-burning hemp wrap, now available in Ontario and Alberta with further national launch coming soon.

  • Hemp’d Khalifuel Redees: A premium indica featuring Khalifa Mints x Grape Gasoline, is meticulously cultivated to deliver a unique boost, harvested at peak ripeness, and perfectly rolled into the signature 10x0.4g straight cut Hemp’d Redees for superior taste and burn. available in Ontario, Alberta, and British Columbia.

  • Darts Berries & Cream and Twisted Citrus: The two latest strain blends joining beyond-belief blends of flavours with fired-up potencies will have you wondering what makes these secret recipes so good. Berries & Cream is the perfect indica blend with berry, sweet and vanilla flavours while Citrus Twist. Both are available in Alberta, while Berries and Cream are available only in British Columbia.

  • Cherry Cheesecake: The perfect sweet treat featuring dramatic purple and orange indica buds flooded with milky trichomes and amber pistils, featuring a cherry, cheese, and sour profile thanks to its Kimbo Kush x Cherry Pie lineage. Available in 5 x 0.5g pre-roll packs in Ontario, Alberta, and British Columbia.

Vapes:

  • Gooey Gold and Cherry Loops: ‘Gooey Gold’ and ‘Cherry Loops’ 1g 510 Vapes both offer an unmatched balance of high potency and rich flavours through a ceramic core, glass cartridge, and hemp mouthpiece. ‘Gooey Gold’ captivates with its sweet caramel flavour profile while ‘Cherry Loops’ features a unique blend of sweet, tart, and tangy notes from cherry, fruity, and citrus flavours. Available in Ontario, Alberta, and British Columbia.

Tilray's adult-use cannabis brands are available in Canada through legal adult-use cannabis retailers and e-commerce channels nationwide. 

For more about each brand, please visit our brand socials including ,  , , , , , , .

Must be of legal age to sip and consume. Enjoy Tilray's cannabis products responsibly.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information on Tilray, visit . and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under U.S. and Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

Contacts:

Media:

Kaitlin Macapagal

Investors

Raphael Gross

203-682-8253



EN
04/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...

 PRESS RELEASE

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich...

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals CC-Pharma-Vereinbarung fördert das Wachstum von Tilray im Vereinigten Königreich und stärkt den Vertrieb über Apotheken- und Krankenhauskanäle NEW YORK und LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass ihr europäisches pharmazeutisches Vertriebsunternehmen CC Pharma eine strategische Vereinbarung mit , einem führenden pharmazeutischen Vertriebspartner...

 PRESS RELEASE

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni g...

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals L’accord avec CC Pharma renforce la croissance de Tilray au Royaume-Uni, consolidant sa distribution auprès des pharmacies et des hôpitaux NEW YORK et LONDRES, 13 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd'hui que son activité de distribution pharmaceutique européenne, CC Pharma, a conclu un accord stratégique avec , un partenaire de distribution pharmaceutique...

 PRESS RELEASE

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement wi...

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with , a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products...

 PRESS RELEASE

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in De...

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen Pharmamarkt DENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass , ihr europäischer Pharmahändler, zu einem der ernannt wurde. Hierbei handelt es sich um eine der renommiertesten und unabhängigsten Auszeichnungen für Innovation bei kleinen und mittleren Unternehmen des La...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch